Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Parasit Vectors ; 17(1): 211, 2024 May 10.
Article de Anglais | MEDLINE | ID: mdl-38730429

RÉSUMÉ

BACKGROUND: The health and productivity of dairy goats continue to be impacted by gastrointestinal nematodes (GIN) and lungworms (LW). Eprinomectin (EPN) is frequently selected for treatment because it is generally effective and does not require a milk withdrawal period. However, some factors, such as lactation, can have an impact on EPN pharmacokinetics and potentially its efficacy. To evaluate whether this can alter the efficacy of Eprecis® 2%, an eprinomectin injectable solution, a study was performed in lactating goats using the dose currently registered in cattle, sheep and goats (0.2 mg/kg). METHODS: This study was a blinded, randomized, controlled trial performed according to the VICH guidelines. Eighteen (18) worm-free lactating goats were included and experimentally challenged on day 28 with a mixed culture of infective gastrointestinal and lung nematode larvae (Haemonchus contortus, Trichostrongylus colubriformis, Teladorsagia circumcincta, Dictyocaulus filaria). At D-1, fecal samples were collected to confirm patent infection in all animals. On D0, the goats were randomly allocated into two groups of nine goats; group 1 was treated with Eprecis® 2% at 0.2 mg/kg BW by subcutaneous injection, while group 2 remained untreated. Fecal samples for egg counts were collected from all animals on days 3, 5, 7, 9, 11 and 14. On D14, all goats were killed, and the abomasum, small intestine and lungs were removed, processed and subsampled to record the number and species of worms. RESULTS: The treatment was well tolerated. After treatment, the arithmetic mean FEC decreased in the treated group and remained < 5 EPG until the end of the study, while the arithmetic mean FEC in the control group remained > 849.0 EPG. At D14, goats in the treated group had very limited or zero total worm counts, whereas all animals from the control group had a high worm burden. The measured efficacy was 100.0% against H. contortus and T. colubriformis, 99.9% against T. circumcincta and 98.0% against D. filaria. CONCLUSIONS: Eprinomectin (Eprecis®, 20 mg/ml), administered at the label dose (0.2 mg/kg), is highly effective against gastrointestinal nematodes and lungworms in lactating goats.


Sujet(s)
Fèces , Maladies des chèvres , Capra , Ivermectine , Lactation , Nématodoses , Animaux , Ivermectine/analogues et dérivés , Ivermectine/administration et posologie , Ivermectine/pharmacocinétique , Ivermectine/usage thérapeutique , Maladies des chèvres/traitement médicamenteux , Maladies des chèvres/parasitologie , Femelle , Nématodoses/médecine vétérinaire , Nématodoses/traitement médicamenteux , Nématodoses/parasitologie , Fèces/parasitologie , Lactation/effets des médicaments et des substances chimiques , Numération des oeufs de parasites/médecine vétérinaire , Injections sous-cutanées/médecine vétérinaire , Anthelminthiques/administration et posologie , Anthelminthiques/usage thérapeutique , Anthelminthiques/pharmacocinétique , Nematoda/effets des médicaments et des substances chimiques , Maladies gastro-intestinales/médecine vétérinaire , Maladies gastro-intestinales/parasitologie , Maladies gastro-intestinales/traitement médicamenteux , Poumon/parasitologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...